The quality life in patients with chronic obstructive pulmonary disease combined with arterial hypertension
DOI:
https://doi.org/10.34287/MMT.4(43).2019.1Abstract
Purpose of the study. Was to investigate life quality in patients with comorbidly pathology of chronic obstructive pulmonary disease in combination with arterial hypertension.
Materials and methods. 77 subjects with a diagnosis of chronic obstructive pulmonary disease stage I–III (according to the GOLD criteria) in combination with arterial hypertension I–III stage. The comparison groups included 30 patients with essential hypertension and 45 patients with chronic obstructive pulmonary disease. All groups were completely comparable by the length and disease severity. All patients underwent general clinical examination, blood pressure measurement, spirometry, electrocardiography, and echocardiography. Study of the life quality in patients was carried out by means of self-questioning using General official Russian-language analogue of the MOS SF-36 questionnaire.
Results. It was determined, that life quality parameters of physical status and psychosocial status were reduced in all patients, but to a greater extent in patients with comorbidity than in patients of the comparison group. Disease duration influenced on life quality. In patients with newly diagnosed chronic obstructive pulmonary disease with a history of marked increase in blood pressure, changes in life quality were more expressed in comparison with the comparison group; at the same time there was tendency of it’s increasing over time. When assessing the relationship between quality of life and parameters of pulmonary ventilation, it was found that depending on the severity of respiratory function disturbances it is directly proportional to decreased quality of life, both physical and psychosocial status. Life quality of in patients with chronic obstructive pulmonary disease worsens due to addition and progression of essential hypertension.
Conclusions. Сomorbidly pathology has a negative impact on physical and psychosocial status of patients, which is significantly reduces life quality and depends on the severity of pulmonary ventilation disturbances, «length of the disease» and hypertension degree.
References
Feshchenko YI, Yashina LO, Dzlyubyk OY et al. Chronic obstructive pulmonary disease: etiology, pathogenesis, classification, diagnosis, therapy (project national agreement). Ukrayinskyy pulmonolohichnyy zhurnal. 2013; 3: 6–12.
Feschenko YI. Actual questions of chronic obstructive pulmonary disease. Ukrayinskyy pulmonolohichnyy zhurnal. 2010; 1: 6–11.
Vogelmeier CF, Criner GJ, Martinez FJ et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med.; 195 (5): 557–582. DOI: 10.1164/rccm.201701–0218PP.
Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005; 128 (4): 2640–2646. DOI: 10.1378/chest.128.4.2640.
Grigorieva NY, Kuznetsov A., Sharabrin EG. The place of chronic obstructive pulmonary disease in the development of the cardiovascular continuum. Serdtse. 2012; 11 (2): 120–125.
Karoli NA, Rebrov AP. Arterial hypertension in patients with bronchial asthma and chronic obstructive pulmonary disease. Clinicist. 2011; 2 (5): 20–30.
Khaletskaya AI, Kuznetsov AN, Scherbinina EV, Fomin IV. Features of the comorbid course of chronic obstructive pulmonary disease and chronic heart failure and their impact on the quality of life of patients. Meditsinskiy Almanakh. 2017; 48 (3): 206–210.
Ovcharenko SI, Galetskkaite YK. Volel BA. Predictors of maladaptive behavior in patients with chronic obstructive pulmonary disease. Pulmonologiya. 2014; 2: 60–68.
Hainsworth R. Cardiovascular control from cardiac and pulmonary vascular receptors. Exp Physiol. 2014; 99 (2) 312–319. DOI: 10.1113/expphysiol.2013.072637.
Bazdirev ED, Gerasimova EB, Polycutina OM et al. Cardiovascular risk factors in patients with chronic obstructive pulmonary disease. Clinicist. 2014; 1: 22–27.
Yagensky AV, Sichkaruk IM. Assessment of quality of life in modern medical practice. Vnutrishnya medytsyna. 2009; 5–6 (17–18); 2428.
Kardos P, Jones PW, Levy ML et al. Primary care physician assessment of COPD severity: European Health-related Quality of Life in COPD study. Eur Resp J. 2010; 36 (54): 4228.
Nekrasov AA, Kuznetsov AN, Melnichenko OB, Kabanova TI. The quality of life of patients with chronic obstructive pulmonary disease and its determinants. Pulmonologiya. 2011; 5: 48–52.
Frolova EB, Yanushev MF Study of the quality of life of patients with COPD in combination with CHF based on the use of the sf-36 questionnaire. Vestnik sovremennoy klinicheskoy meditsiny. 2013; 3 (4): 21–25.
